Puttarajappa Chethan M, Urbanski Megan, Fallahzadeh M Kazem, Budhiraja Pooja, Balaraman Vasanthi, Butsch W Scott, Morford Harry, Anand Prince M, Woodside Kenneth J, Orandi Babak J
Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Department of Surgery, Emory University, Atlanta, Georgia, USA.
Am J Transplant. 2025 May 31. doi: 10.1016/j.ajt.2025.05.033.
There is growing kidney transplant program-level interest in addressing obesity. The American Society of Transplantation Kidney Pancreas Community of Practice Obesity Work Group surveyed US programs to characterize evaluation, listing, and weight management practices. A web-based survey was administered to professionals involved in kidney transplant care (transplant nephrologists/surgeons/coordinators/dietitians, endocrinologists, bariatric surgeons, and obesity medicine specialists) from May 2024 to September 2024. The 275 respondents from 113 programs represented 70.7% of the US transplant volume. A body mass index (BMI) cutoff-commonly 40 kg/m-is used for evaluation/listing at 72.5%/74.3% of programs. For recipients, BMI 40 kg/m was the most common threshold for referral for medical and surgical weight loss. Most (73.4%) programs have weight management programs within their institution; 19.4% have a program integrated into their transplant program. One of the most common reasons for not referring for weight management was a preference that primary care providers/general nephrologists manage this, particularly pretransplant. Of programs, 27.6% offer robotic kidney transplantation; 38.5% offer it only to patients above a BMI threshold (32-40 kg/m). Obesity management is heterogeneous. Most use a BMI cutoff-typically 40 kg/m-for evaluation and listing. These data provide the most comprehensive and contemporary overview of practices at US programs.
肾脏移植项目层面对于解决肥胖问题的兴趣日益浓厚。美国移植学会肾脏胰腺实践社区肥胖问题工作组对美国各项目进行了调查,以描述评估、列入名单及体重管理的做法。2024年5月至2024年9月,对参与肾脏移植护理的专业人员(移植肾病学家/外科医生/协调员/营养师、内分泌学家、减肥外科医生和肥胖医学专家)进行了一项基于网络的调查。来自113个项目的275名受访者占美国移植量的70.7%。72.5%/74.3%的项目在评估/列入名单时使用体重指数(BMI)临界值——通常为40kg/m²。对于受者,BMI 40kg/m²是转诊进行医学和手术减肥的最常见阈值。大多数(73.4%)项目在其机构内设有体重管理项目;19.4%的项目有一个整合到其移植项目中的项目。不转诊进行体重管理的最常见原因之一是倾向于由初级保健提供者/普通肾病学家来管理,尤其是在移植前。在各项目中,27.6%提供机器人肾脏移植;38.5%仅向BMI高于临界值(32 - 40kg/m²)的患者提供。肥胖管理存在差异。大多数项目在评估和列入名单时使用BMI临界值——通常为40kg/m²。这些数据提供了美国各项目做法最全面和最新的概述。